Does ROSUVASTATIN Cause Pulmonary embolism? 239 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 239 reports of Pulmonary embolism have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.7% of all adverse event reports for ROSUVASTATIN.
239
Reports of Pulmonary embolism with ROSUVASTATIN
0.7%
of all ROSUVASTATIN reports
20
Deaths
89
Hospitalizations
How Dangerous Is Pulmonary embolism From ROSUVASTATIN?
Of the 239 reports, 20 (8.4%) resulted in death, 89 (37.2%) required hospitalization, and 17 (7.1%) were considered life-threatening.
Is Pulmonary embolism Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 239 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Pulmonary embolism?
RIVAROXABAN (3,282)
LENALIDOMIDE (2,976)
APIXABAN (2,714)
ETHINYL ESTRADIOL\ETONOGESTREL (2,370)
TESTOSTERONE (2,043)
RITUXIMAB (1,764)
ADALIMUMAB (1,663)
PREDNISONE (1,586)
METHOTREXATE (1,508)
DEXAMETHASONE (1,336)
Which ROSUVASTATIN Alternatives Have Lower Pulmonary embolism Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN